We serve Chemical Name:4-Methoxy-1H-indazole-6-carboxylic acid CAS:40990-53-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Methoxy-1H-indazole-6-carboxylic acid
CAS.NO:40990-53-2
Synonyms:1H-Indazole-6-carboxylic acid, 4-methoxy-;4-Methoxy-1H-indazole-6-carboxylic acid;4-methoxy-indole-6-carboxylic acid;4-Methoxy-indol-6-carbonsaeure;4-Methoxy-1H-indazole-6-caboxylic acid
Molecular Formula:C9H8N2O3
Molecular Weight:192.171
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:467.6±25.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.689
PSA:75.21000
Exact Mass:192.053497
LogP:1.62
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1H-Indazole-6-carboxylic acid, 4-methoxy- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Methoxy-1H-indazole-6-caboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Methoxy-indol-6-carbonsaeure Use and application,4-Methoxy-indol-6-carbonsaeure technical grade,usp/ep/jp grade.
Related News: The Company has run a comprehensive range of specialized in vitro and in vivo tests on its patent-pending novel compounds to select the optimal psychedelic drug candidate for progressing towards human clinical trials. benzyl (S)-(3-(5-(1-(2-amino-2-methylpropanamido)-2-(benzyloxy)ethyl)-1H-tetrazol-1-yl)propyl)carbamate manufacturers “The approval of Verquvo in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies,” he added. Peptide, (Xaa-Leu-Xaa-Gly-Xaa-Phe-Xaa-Xaa-Asp-Gly) suppliers Officials did, however, acknowledge that there’s growing evidence an extra jab may enhance the antibody response in immunocompromised people. Some small studies suggest up to 50% of people with no antibody response after the authorized regimen of two mRNA jabs developed a response after an additional dose, said CDC’s Sara Oliver, M.D. 2-[(E)-2-(3-methoxy-4-propan-2-yloxyphenyl)ethenyl]-1,3-thiazole-4-carboxylic acid vendor & factory.
